PainReform
(NASDAQ:PRFX)
$1.84
0[0.00%]
At close: Mar 15
$1.84
0[0.00%]
After Hours: 5:16PM EDT

GET A REPORT ON PRFX SENT RIGHT TO YOUR INBOX

37.5%
Overview Rating
Speculative
Technicals Analysis
33
0100
Financials Analysis
40
0100

PainReform Stock (NASDAQ:PRFX), Quotes and News Summary

PainReform Stock (NASDAQ: PRFX) stock price, news, charts, stock research, profile.
Open$1.865
Close$1.840
Volume / Avg.4.634K / 23.319K
Day Range1.840 - 1.896
52 Wk Range1.822 - 26.410
Market Cap$3.180M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
40
Short Interest
0.35%
Days to Cover1

Recent News

40%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Ratings
Strong Buy
Buy
Hold
Sell
Strong Sell
About
Sector
Healthcare
Industry
N/A
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulat...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
PRFX

FAQ

Q

How do I buy PainReform (PRFX) stock?

A

You can purchase shares of PainReform (NASDAQ: PRFX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are PainReform's (PRFX) competitors?

A

There are no as such competitors for PainReform.

Q

What is the target price for PainReform (PRFX) stock?

A

There is no analysis for PainReform

Q

Current Stock Price for PainReform (PRFX)?

A

The stock price for PainReform (NASDAQ: PRFX) is $1.84 last updated March 15, 2024 at 5:16 PM EDT.

Q

Does PainReform (PRFX) pay a dividend?

A

There are no upcoming dividends for PainReform.

Q

When is PainReform (NASDAQ:PRFX) reporting earnings?

A

PainReform’s Q1 earnings are confirmed for Monday, May 13, 2024.

Q

Is PainReform (PRFX) going to split?

A

There is no upcoming split for PainReform.

Q

What sector and industry does PainReform (PRFX) operate in?

A

PainReform is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the NASDAQ.